Talking Points and FAQs: Cases of Paxlovid Rebound (English, Spanish)

Talking Points and FAQs: Cases of Paxlovid Rebound (English, Spanish)

Date posted: June 7, 2022
Last reviewed: June 07, 2022

The Public Good Projects in collaboration with the Hispanic Communications Network

Talking points and FAQs discuss the recent reports of COVID rebound among people who have taken the COVID-19 treatment, Paxlovid. Some people have reported recovering from COVID-19 after taking Paxlovid but testing positive again two to eight days later and are classified as "rebound" cases. They may or may not have symptoms. The talking points emphasize that the Centers for Disease Control and Prevention continue to recommend Paxlovid for people at high risk of developing severe illness and encourage people who experience a rebound case to re-isolate for at least 5 days. The FAQs cover similar information. A related graphic is available here: Social Media: Graphic on What To Do If You Experience Paxlovid Rebound (English, Spanish).

Download
Report